PrescribeIT and TPP Type 1 Prescribing Requirements
The Tracked Prescription Program (TPP) Steering Committee provided an approval for the use of PrescribeIT for methadone prescribing in September 2020, waiving the requirement for a TPP form to be used in this instance.
At their May 4, 2023 meeting TPP Steering Committee will be considering a request from Canada Health Infoway for broader exemption from the use of TPP secure prescription forms for all type 1 TPP drugs prescribed electronically using PrescribeIT.
Understanding that some Alberta prescriber and pharmacy workflows are already using PrescribeIT for TPP type 1 drug prescribing ,drug, TPP SC has granted an interim approval to allow such prescribing to continue to minimize risk of interruptions to patient care.
Prescribers and pharmacies connected with PrescribeIT may temporarily continue to use the system for electronic prescribing of TPP monitored medications without requiring the use of a TPP form. Further updates and guidance will be issued following TPP Steering Committee’s deliberations in May.
Interim exemption from use of secure TPP Alberta prescription forms, for type 1 TPP-monitored drugs, is permitted if the following conditions are met:
both the prescriber and pharmacy are PrescribeIT enabled and using PrescribeIT system-to-system communications, and
the patient has choice of the pharmacy at which their prescription(s) is filled, i.e., patients must not be directed to only PrescribeIT-enabled pharmacies.
